Clinical trial
Characterization of Novel Molecular Tools for the Epidemiological Surveillance of Antimalarial Drug Resistance in Mali
NCT00127998 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of Novel Molecular Tools for the Epidemiological Surveillance of Antimalarial Drug Resistance in Mali
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- Not reported
- Enrollment
- 1,011
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.